SEC Form 4 · accession 0001179110-18-008243
CATABASIS PHARMACEUTICALS INC · CATB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Burt A Adelman
Director
Period of report
Jun 7, 2018
Accepted (ET)
Jun 7, 2018 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454789
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.48 | Jun 7, 2018 | A | 14,000 | A | — | Jun 6, 2028 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F11. This option was granted on June 7, 2018 and is scheduled to vest in full on June 7, 2019.